Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue-Faye Siow

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Brain Communications|July 9, 2024
Clinical phenotyping is key to differentiating <i>RFC1</i>-associated neuropathy from immune-mediated neuropathySue-Faye Siow, Kishore Raj Kumar
Journal of Palliative Medicine|May 29, 2014
Discharge patterns, survival outcomes, and changes in clinical management of hospitalized adult patients with cancer with a do-not-resuscitate orderArun A Azad, Sue-Faye Siow, Ali Tafreshi, et al.
Frontiers in Neurology|October 18, 2019
Motor Evoked Potentials in Hereditary Spastic Paraplegia-A Systematic ReviewSue-Faye Siow, Ruaridh Cameron Smail, Karl Ng, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 15, 2024
Genetic Testing of Movements Disorders: A Review of Clinical UtilityDennis Yeow, Laura I Rudaks, Sue-Faye Siow, et al.
Frontiers in Neuroscience|May 5, 2023
Reduced acetylated α-tubulin in <i>SPAST</i> hereditary spastic paraplegia patient PBMCsGautam Wali, Sue-Faye Siow, Erandhi Liyanage, et al.
Cerebellum (London, England)|December 16, 2024
Designing and Validating a Hereditary Spastic Paraplegia-Specific Quality of Life Rating Scale (HSPQoL)Sue Faye Siow, Jane Fleming, Kristine Barlow-Stewart, et al.
Genes|September 28, 2023
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping ReviewSue-Faye Siow, Dennis Yeow, Laura I Rudaks, et al.
The Journal of Dermatology|June 26, 2024
The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1Brieana Dance, Alice Dardare, Jane Fleming, et al.
Journal of Genetic Counseling|November 26, 2024
Reproductive decision-making experiences of Australian adults with neurofibromatosis type 1 and schwannomatosisTina Gonzalez, Alison McLean, Jane Fleming, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|September 3, 2024
Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1Jonathan C L Lau, Jane Fleming, Martin Good, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Brain Communications|July 9, 2024
Clinical phenotyping is key to differentiating <i>RFC1</i>-associated neuropathy from immune-mediated neuropathySue-Faye Siow, Kishore Raj Kumar
Journal of Palliative Medicine|May 29, 2014
Discharge patterns, survival outcomes, and changes in clinical management of hospitalized adult patients with cancer with a do-not-resuscitate orderArun A Azad, Sue-Faye Siow, Ali Tafreshi, et al.
Frontiers in Neurology|October 18, 2019
Motor Evoked Potentials in Hereditary Spastic Paraplegia-A Systematic ReviewSue-Faye Siow, Ruaridh Cameron Smail, Karl Ng, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|January 15, 2024
Genetic Testing of Movements Disorders: A Review of Clinical UtilityDennis Yeow, Laura I Rudaks, Sue-Faye Siow, et al.
Frontiers in Neuroscience|May 5, 2023
Reduced acetylated α-tubulin in <i>SPAST</i> hereditary spastic paraplegia patient PBMCsGautam Wali, Sue-Faye Siow, Erandhi Liyanage, et al.
Cerebellum (London, England)|December 16, 2024
Designing and Validating a Hereditary Spastic Paraplegia-Specific Quality of Life Rating Scale (HSPQoL)Sue Faye Siow, Jane Fleming, Kristine Barlow-Stewart, et al.
Genes|September 28, 2023
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping ReviewSue-Faye Siow, Dennis Yeow, Laura I Rudaks, et al.
The Journal of Dermatology|June 26, 2024
The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1Brieana Dance, Alice Dardare, Jane Fleming, et al.
Journal of Genetic Counseling|November 26, 2024
Reproductive decision-making experiences of Australian adults with neurofibromatosis type 1 and schwannomatosisTina Gonzalez, Alison McLean, Jane Fleming, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|September 3, 2024
Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1Jonathan C L Lau, Jane Fleming, Martin Good, et al.
Pageof 2